Relief announced that U.S. collaboration had reporteded successful commercial formulation for aviptadil
On Jul. 23, 2021, RELIEF THERAPEUTICS announced that the parent company of its collaboration partner, NRx Pharmaceuticals, reported…
On Jul. 23, 2021, RELIEF THERAPEUTICS announced that the parent company of its collaboration partner, NRx Pharmaceuticals, reported…
On Jul. 23, 2021, Pfizer and BioNTech announced that the U.S. government had purchased an additional 200 million…
On Jul. 23, 2021, Moderna announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human…
On Jul. 21, 2021, Humanigen announced its development and commercialization partners for South Korea and the Philippines, Telcon…
On Jul. 22, 2021, the National Institutes of Health announced it had renewed grants to seven regional centers…
On Jul. 22, 2021, Moderna announced a new supply agreement with Taiwan for 20 million doses of Moderna’s…
On Jul. 22, 2021, Twist Bioscience announced that it had started shipping its synthetic RNA reference controls for…
On Jul. 21, 2021, Pfizer and BioNTech announced the signing of a letter of intent with The Biovac…
On Jul. 21, 2021, Sorrento Therapeutics announced that COVID-19 patients had been dosed in its Phase 2 efficacy…
On Jul. 20, 2021, Roche announced that Japanメs Ministry of Health, Labour and Welfare (MHLW) had approved Ronapreveル(casirivimab…
On Jul. 28, 2021, the National Institutes of Health announced that by studying lab-grown neurons derived from skin…
On Jul. 20, 2021, Moderna announced that the Ministry of Health, Labour and Welfare of Japan (MHLW) and…
On Jul. 20, 2021, Regeneron announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) had approved Regeneron’s…
On Jul. 16, 2021, Merck announced the U.S. Food and Drug Administration (FDA) had approved VAXNEUVANCE (Pneumococcal 15-valent…
On Jul. 16, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had granted…
On Jul. 16, 2021, the U.S. Centers for Disease Control and Prevention (CDC) announced and the Texas Department…
On Jul. 15, 2021, Corvus Pharmaceuticals announced that it had discontinued its Phase 3 study of mupadolimab for…
On Jul. 15, 2021, iBio announced that preclinical studies of IBIO-202, its subunit vaccine candidate that targets the…
On Jul. 14, 2021, Hologic announced that it had obtained a CE Mark for the use of saliva…
On Jul. 13, 2021, RELIEF THERAPEUTICS reported that its collaboration partner, NRx Pharmaceuticals, and Quantum Leap Healthcare Collaborativeル…
On Jul. 13, 2021, the Food and Drug Administration (FDA) revisions to the vaccine recipient and vaccination provider…
On Jul. 12, 2021, BioNTech announced that Fosun Industrial Co. had reached advance procurement agreements for the mRNA-based…
On Jul. 12, 2021, Moderna announced a supply agreement with the government of Argentina for 20 million doses…
On Jul. 12, 2021, Gavi, the Vaccine Alliance, announced that it had signed advance purchase agreements with Sinopharm…
On Jul. 9, 2021, Humanigen announced its submission for Marketing Authorization for lenzilumab in COVID-19, begun in Jun….
On Jul. 9, 2021, a federal jury convicted a timber thief who authorities said started a large forest…
On Jul. 9, 2021, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to Ortho-Clinical…
On Jul. 8, 2021, the National Institutes of Health (NIH) announced that a new study authored by scientists…
On Jul. 8, 2021, the National Institutes of Health (NIH) reported that the overall cancer death rates continue…
On Jul. 8, 2021, access to the world’s largest browsable resource linking rare protein-coding genetic variants to human…